ArticleBMC surgery2025
Safety and feasibility of the bowel-first versus conventional approach in intra-abdominal penetrating Crohn's disease: a propensity score-matched study.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPenetrating Crohn’s disease (CD) is a severe phenotype marked by fistulae, abscesses, and complex intra-abdominal inflammation, often necessitating surgical intervention. Surgical management is particularly challenging in the presence of dense adhesions and severe mesenteric thickening. The bowel-first approach—where the diseased bowel is transected prior to mesenteric dissection—has been proposed as an alternative to conventional techniques, yet comparative evidence remains limited.
methodsWe conducted a retrospective cohort study of adult patients with penetrating CD who underwent elective intestinal resection at our center between January 2019 and December 2022. Patients were categorized into bowel-first or conventional groups according to the surgical technique used. Propensity score matching (1:1) was performed based on demographic, laboratory, and disease-related variables to balance baseline characteristics. The primary outcomes were overall and major postoperative complication rates. Secondary outcomes included total operative time, bowel resection and anastomosis time, intraoperative blood loss, and length of postoperative hospital stay.
resultsA total of 122 patients were included (91 conventional, 31 bowel-first). After matching, 31 patients remained in each group with well-balanced baseline characteristics. Total operative times were comparable between the bowel-first and conventional groups (211.13 (55.84) min vs. 239.39 (67.20) min; P = 0.077). However, bowel resection and anastomosis time was significantly shorter in the bowel-first group (48.71 (9.83) min) compared to the conventional group (65.81 (17.56) min; P < 0.001). No significant differences were observed in intraoperative blood loss (80 [50, 150] mL vs. 100 [50, 200] mL; P = 0.492) or postoperative hospital stay (10 [8, 20] days vs. 9 [8, 15] days; P = 0.676). Rates of overall postoperative complications (35.48% vs. 32.26%; P = 0.788) and major complications (6.45% in both groups; P = 1.000) were also similar.
conclusionsThe bowel-first approach is a safe and feasible alternative to conventional surgery for intra-abdominal penetrating Crohn’s disease. This technique significantly reduces bowel resection and anastomosis time without increasing operative risk or length of hospital stay and may be especially advantageous for patients with severe mesenteric thickening or complex adhesions. Further prospective studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.